TABLE 5
FROM:
Improving the cost-effectiveness of Chlamydia screening with targeted screening strategies
D Evenden, P R Harper, S C Brailsford and V Harindra
BACK TO ARTICLETable 5. Base-case modelling parameters
| Parameter | Value |
|---|---|
| Population | 10 000 |
| Percentage of population initially in high-risk group | 2.5% |
| Percentage of population initially in low-risk group | 97.5% |
| Risk group mixing probability (within-group) | 90% |
| Risk group mixing probability (between-group) | 10% |
| High- and low-risk group sequelae fraction | 20% |
| Low-risk group partnership frequency | 1 every 5 years |
| High-risk group partnership frequency | 1 every 2 months |
| High- to low-risk group mixing ratio | 10% |
| Infection mean recovery time | 30 months |
| Modelling period | 24 months |
| Screening cost | £10 |
| Treatment cost | £10 |
| Sequelae cost | £2000 |
